VJHemOnc is committed to improving our service to you

Share this video  

VJHemOnc is committed to improving our service to you

EHA 2022 | Updates from the MonumenTAL-1 trial

Monique Minnema, MD, PhD, University Medical Center Utrecht, Utrecht, Netherlands, shares some updates from the Phase I MonumenTAL-1 trial (NCT04634552) evaluating the safety and efficacy of talquetamab at two recommended doses in patients with relapsed/refractory (R/R) multiple myeloma. This interview took place at the European Hematology Association (EHA) Congress 2022 held in Vienna, Austria.

Sign-up for our Newsletter!

Keep up to date with all the latest news with our monthly newsletter